SCHEMBL6781682

SCHEMBL6781682

O=C(O)C=Cc1cc2ncnc(NC(=O)Nc3ccccc3Cl)c2s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.44
PPIA P62937 1/20 0.42
KMT2A Q03164 7/20 0.42
MEN1 O00255 6/20 0.42
RAB9A P51151 5/20 0.42
NPC1 O15118 4/20 0.42
POLB P06746 3/20 0.42
CASP3 P42574 2/20 0.42
SENP7 Q9BQF6 2/20 0.42
GRIK1 P39086 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 2/20 0.41
MAPT P10636 4/20 0.41
NR1I2 O75469 1/20 0.40
KDR P35968 1/20 0.39
KDM4E B2RXH2 3/20 0.39
GAA P10253 2/20 0.39
MAPK1 P28482 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4419740 0.90 EGFR (0.38) KMT2AMEN1MAPTNPSR1EGFR
SCHEMBL4419732 0.90 EGFR (0.38) KMT2AMEN1MAPTNPSR1EGFR
Hydrochloric Acid SCHEMBL4432011 0.89 EGFR (0.37) AURKAKMT2AMEN1NPSR1EGFR
Hydrochloric Acid SCHEMBL4432013 0.89 EGFR (0.37) AURKAKMT2AMEN1NPSR1EGFR
SCHEMBL6771114 0.72 EGFR (0.45) AURKAKDRKDM4EEGFRALDH1A1
SCHEMBL6771123 0.72 EGFR (0.45) AURKAKDRKDM4EEGFRALDH1A1
SCHEMBL6781420 0.71 EGFR (0.43) AURKAEGFR
SCHEMBL4417586 0.69 IKBKB (0.46) AURKAKMT2ARAB9AKDRMAPK1
SCHEMBL4417588 0.69 IKBKB (0.46) AURKAKMT2ARAB9AKDRMAPK1
SCHEMBL4431418 0.66 STK17B (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6806274-B1 IMMUNOREGULATION OR IMMUNOSUPPRESSIVE AGENTS; TYROSINE KINASE INHIBITORS; PREVENTING ORGAN TRANSPLANT REJECTION; AUTOIMMUNE CONDITIONS; REDUCED SIDE EFFECTS ASTRAZENECA UK LIMITED (GB) 2004-10-19 US disclosed